Sign up Australia
Proactive Investors - Run By Investors For Investors

Euro Manganese gives hope for IPOs with stellar debut

The company’s CDIs powered up 6 cents to 32 cents by the toll of the bell yesterday.
ASX chart with arrow pointing up
Like Althea Group, Euro Manganese gained after floating

Euro Manganese Inc (ASX:EMN) (TSX-V:EMN) added an impressive 23.1% on its first day of trading on the Australian Securities Exchange after raising around $9.2 million from its initial public offering.

The company ended yesterday with a $62.72 million value.

READ: IPO Wealth Fund attracts $50 million in investments and is well on way to $100 million


Euro Manganese raised $6.2 million from Australian investors, with new additions to the company’s register being mostly new and existing domestic and international investors.

The remainder of the $9.2 million was from a dual listing on the TSX-Venture Exchange in Canada.

Euro Manganese aims to develop one of Europe’s largest manganese resources — the Chvaletice Manganese Project found in the Czech Republic

The company’s general strategy is to focus is on production of ultra-high-purity and environmentally superior manganese products and the emerging major cluster of lithium-ion battery industries in Europe.

Noteworthy milestone

President and CEO Marco Romero said, “The successful completion of our dual IPO, in the world’s leading equity capital markets for our sector, is a noteworthy milestone for EMN.

“It enables us to continue our steady progress towards the development of this strategic manganese resource in the heart of Europe.

“It brings us one step closer to our goal of becoming a highly-competitive, reliable and environmentally superior supplier of ultra-high-purity manganese products, satisfying the requirements of the most demanding customers.”

Euro Manganese’s premium debut followed Althea Group Holdings Limited’s (ASX:AGH) stand-out debut on September 21, where it added a gob-smacking 180% to its issue price.

Euro’s fellow debutante Althea had made its first turn-out at the ASX on the same day as Archtis Limited (ASX:AR9) which slipped 7.5%.

Three other debutantes gained by the time the bell tolled on their first day, while one other slipped.

READ: BetterCells’ IPO session lays out business focus and displays OligoScan testing capacity

The September trend for more gains than losses on debut followed six slip-down in August, one no-changer and just one positive debutante that month.

ASX Ltd (ASX:ASX) has 31 companies listed as having upcoming floats and listing, the soonest being Cowan Lithium Limited (ASX:COW) next Monday, October 8.

A number of other unlisted companies, such as BetterCells, are also generating interest in public floats as they follow a path towards what they hope will be a successful listing on a new market.

Euro Manganese CDIs added 6 cents, or 23.1%, to close at 32 cents yesterday and this morning has traded up to 33 cents.

View full EMN profile View Profile

Euro Manganese Inc Timeline

Related Articles

KSZ holds potential for world class base and precious metals deposits
Signpost saying Nevada
March 28 2018
The near-term transition of the Eureka Gold Project to a cash-generating asset will be a major milestone for Tyranna.
September 12 2018
Bluejay is now sending off product samples to potential customers

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use